STOCK TITAN

Elevance Health Inc Stock Price, News & Analysis

ELV NYSE

Welcome to our dedicated page for Elevance Health news (Ticker: ELV), a resource for investors and traders seeking the latest updates and insights on Elevance Health stock.

Elevance Health, Inc. (NYSE: ELV) generates a steady stream of news as a major participant in the direct health and medical insurance carriers industry. Company updates frequently focus on financial performance, member experience initiatives, digital tools, and community health programs. Investors and observers following ELV news can see how Elevance Health communicates its strategy as a lifetime, trusted health partner serving over 109 million consumers through medical, pharmacy, behavioral, clinical, home health, and complex care solutions.

News coverage often includes earnings results and guidance, such as quarterly financial releases that detail segment performance for Health Benefits and Carelon, membership trends across commercial, Medicare, Medicaid, and Federal Employee Program lines, and commentary on benefit expense ratios and operating metrics. The company also issues announcements about upcoming conference calls and webcasts where management reviews results and outlook with investors.

Another key theme in Elevance Health news is the evolution of the healthcare consumer experience. Articles describe AI-enabled digital solutions, including the Virtual Assistant available through the Sydney Health app, which helps members understand benefits, compare costs, and find in-network providers. The company also highlights care management programs, concierge-style support for serious illnesses, and models such as “My Health Advocate” in affiliated Medicare plans.

Elevance Health news frequently covers whole-health and community initiatives. Examples include Food as Medicine partnerships with the National Association of Community Health Centers, school-based fitness facility upgrades, and expanded access to doula care and social supports in certain Medicare Advantage and Medicaid plans. Governance developments, such as the appointment of independent directors to the board and related committee assignments, are also reported through press releases and SEC-linked announcements.

By reviewing the ELV news feed on this page, readers can follow financial disclosures, strategic initiatives, digital and clinical innovations, and community-focused programs that shape Elevance Health’s role in the health benefits and healthcare services landscape.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.29%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.62%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.16%
Tags
none
Rhea-AI Summary

Elevance Health reported robust first-quarter results for 2023, with a GAAP net income of $8.30 per share, including negative adjustments of $1.16 per share. Adjusted net income reached $9.46 per share. Operating revenue grew by 10.6% year-over-year to $41.9 billion, driven by an increase in medical membership to 48.1 million, up by 1.3 million members. The company declared a second-quarter dividend of $1.48 per share. Operating cash flow improved to approximately $6.5 billion, bolstered by early premium payments. Notably, operating gain also increased by 16.6% to $2.8 billion. The company anticipates GAAP net income exceeding $29.50 per share for the year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.33%
Tags
-
Rhea-AI Summary

Elevance Health (NYSE: ELV) will announce its first quarter 2023 financial results on April 19, 2023, at 6:00 a.m. EDT. A conference call to discuss these results and the company's outlook will follow at 8:30 a.m. EDT. Interested parties should dial in at least 15 minutes prior to the call using the provided numbers, including 888-947-9963 for domestic access. The call will also be available via webcast, and a replay can be accessed from 11:30 a.m. EDT on the same day until the end of May 19, 2023.

Elevance Health is dedicated to enhancing health outcomes, serving approximately 119 million people through a comprehensive range of healthcare solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
conferences earnings
-
Rhea-AI Summary

Continental General Insurance Company announced a definitive agreement to acquire a block of long-term care policies from Elevance Health (NYSE: ELV). This strategic move represents one of the few successful long-term care transactions in a decade, aimed at enhancing Continental General's TPA services. The acquisition furthers Continental General's mission to become a leading acquisition partner in the long-term care sector. The deal, set to close on April 3, 2023, will leverage Continental General’s over 60 years of insurance management experience for policyholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.19%
Tags
Rhea-AI Summary

The Advancing Health Together: Progress Report from Elevance Health (NYSE: ELV) highlights its partnerships with care providers to enhance health access, outcomes, and affordability. The report reveals that 80% of a person’s health is influenced by factors beyond the doctor's office, prompting Elevance Health to utilize its extensive data to support care providers. Currently, Elevance serves over 47.5 million Americans and manages more than 1.7 million care provider relationships nationwide. The company emphasizes the importance of collaboration in achieving measurable improvements in whole health.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.6%
Tags
none
-
Rhea-AI Summary

The Standard has announced a definitive agreement to acquire Elevance Health's Life & Disability business. This strategic move combines the strengths of both companies, emphasizing their commitment to customer service and benefits administration. The Standard will operate under its brand, incorporating Elevance's employees and operations. The partnership aims to enhance distribution channels, bringing additional life and disability insurance products to customers. Upon closing, The Standard will gain access to Elevance's portfolio, serving approximately 4.8 million covered lives in 14 states, thereby accelerating its growth and market presence in the U.S.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.51%
Tags
partnership acquisition
-
Rhea-AI Summary

Anthem Blue Cross and Blue Shield in Georgia has launched Virtual-First health plans, providing eligible members with affordable access to virtual care options. The plans include an AI-driven symptom checker and support for chronic condition management. Starting from July 2023, these plans aim to improve healthcare experiences by seamlessly connecting virtual and in-person care through the Sydney Health app, available 24/7. Members benefit from various cost-share options, potentially including no coinsurance for virtual care. These services will also cater to national account ASO clients beginning January 1, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.59%
Tags
none
Rhea-AI Summary

Elevance Health (NYSE: ELV) will host an Investor Conference on March 23, 2023, in New York City. The event features presentations and Q&A sessions with senior leadership, webcast live from 8:00 a.m. ET to 12:00 p.m. ET. Interested parties can register for the webcast here or visit ElevanceHealth.com. Presentations will be available for download later on the website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.44%
Tags
conferences

FAQ

What is the current stock price of Elevance Health (ELV)?

The current stock price of Elevance Health (ELV) is $372.84 as of January 14, 2026.

What is the market cap of Elevance Health (ELV)?

The market cap of Elevance Health (ELV) is approximately 82.4B.
Elevance Health Inc

NYSE:ELV

ELV Rankings

ELV Stock Data

82.38B
221.87M
0.17%
93.25%
1.2%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
INDIANAPOLIS